Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prospectively scored pulmonary toxicities in non-small cell lung cancer: Results from a randomized phase II dose escalation trial.
Lutz CM, Knap MM, Hoffmann L, Møller DS, Hansen O, Brink C, Schytte T, Nyhus CH, McCulloch T, Borissova S, Alber M, Khalil AA. Lutz CM, et al. Among authors: nyhus ch. Clin Transl Radiat Oncol. 2020 Nov 26;27:8-14. doi: 10.1016/j.ctro.2020.11.013. eCollection 2021 Mar. Clin Transl Radiat Oncol. 2020. PMID: 33385069 Free PMC article.
A randomized phase II trial of concurrent chemoradiation with two doses of radiotherapy, 60Gy and 66Gy, concomitant with a fixed dose of oral vinorelbine in locally advanced NSCLC.
Hansen O, Knap MM, Khalil A, Nyhus CH, McCulloch T, Holm B, Brink C, Hoffmann L, Schytte T. Hansen O, et al. Among authors: nyhus ch. Radiother Oncol. 2017 May;123(2):276-281. doi: 10.1016/j.radonc.2017.03.017. Epub 2017 Apr 11. Radiother Oncol. 2017. PMID: 28410809 Clinical Trial.
Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan.
Mau-Sørensen M, Gerner-Rasmussen J, Hansen O, Holm B, Nyhus CH, McCulloch T, Nielsen HA, Wedervang K, Rytter C, Jeppesen N, Langer SW. Mau-Sørensen M, et al. Among authors: nyhus ch. Acta Oncol. 2023 Dec;62(12):1979-1982. doi: 10.1080/0284186X.2023.2278173. Epub 2023 Nov 25. Acta Oncol. 2023. PMID: 37934081 Clinical Trial. No abstract available.
Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study.
Møller DS, Nielsen TB, Brink C, Hoffmann L, Lutz CM, Drøgemüller Lund M, Hansen O, Schytte T, Khalil AA, Knap MM, Nyhus CH, Ottosson W, Sibolt P, Borissova S, Josipovic M, Persson G, Appelt AL. Møller DS, et al. Among authors: nyhus ch. Radiother Oncol. 2017 Aug;124(2):311-317. doi: 10.1016/j.radonc.2017.06.022. Epub 2017 Jul 5. Radiother Oncol. 2017. PMID: 28688525 Free article. Clinical Trial.